Healx (Series C)
Funding Details
Awarder
RSS - techcrunch.com
Date Award
August 2, 2024
Vertical
Biotech and Health
Funding URL
View Funding Page
Funding Amount
$47,000,000
Company Info
Founding Year
2014
Traction
Healx has previously secured investigational new drug (IND) approval from the U.S. FDA for fragile X syndrome and is in the early AI-discovery or preclinical stages for a number of other conditions spanning oncology, renal, and neurology.
Organizations Involved
Children’s Tumor Foundation
Founders
Tim Guilliams, David Brown
Market
Rare Diseases
Location
Cambridge, UK
Coinvestors
Atomico, R42, Ayana Capital, Balderton, Btov, Global Brain, Jonathan Milner, O2h, VU Venture Partners
Company Description

Healx is a rare disease biotechnology company that uses generative AI for drug discovery.

Links
WebsiteCrunchbaseLinkedInTwitter
Back to HomeBack to Biotech and Health DealsView Funding Announcement